» Articles » PMID: 28407643

The Use of Mathematical Models of Chlamydia Transmission to Address Public Health Policy Questions: A Systematic Review

Overview
Journal Sex Transm Dis
Date 2017 Apr 14
PMID 28407643
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mathematical models of chlamydia transmission can help inform disease control policy decisions when direct empirical evaluation of alternatives is impractical. We reviewed published chlamydia models to understand the range of approaches used for policy analyses and how the studies have responded to developments in the field.

Methods: We performed a literature review by searching Medline and Google Scholar (up to October 2015) to identify publications describing dynamic chlamydia transmission models used to address public health policy questions. We extracted information on modeling methodology, interventions, and key findings.

Results: We identified 47 publications (including two model comparison studies), which reported collectively on 29 distinct mathematical models. Nine models were individual-based, and 20 were deterministic compartmental models. The earliest studies evaluated the benefits of national-level screening programs and predicted potentially large benefits from increased screening. Subsequent trials and further modeling analyses suggested the impact might have been overestimated. Partner notification has been increasingly evaluated in mathematical modeling, whereas behavioral interventions have received relatively limited attention.

Conclusions: Our review provides an overview of chlamydia transmission models and gives a perspective on how mathematical modeling has responded to increasing empirical evidence and addressed policy questions related to prevention of chlamydia infection and sequelae.

Citing Articles

Impact of a potential Chlamydia vaccine in the USA: mathematical modelling analyses.

Makhoul M, Ayoub H, Awad S, Chemaitelly H, Abu-Raddad L BMJ Public Health. 2025; 2(1):e000345.

PMID: 40018092 PMC: 11812766. DOI: 10.1136/bmjph-2023-000345.


Public willingness to receive chlamydia, gonorrhea, syphilis, and trichomoniasis vaccines: a scoping review.

Valleroy T, Garon C, Perroud J, Wagner A BMC Health Serv Res. 2023; 23(1):1290.

PMID: 37996885 PMC: 10668406. DOI: 10.1186/s12913-023-10334-9.


Serological Investigation of Bovine in Wasit Province, Iraq.

Al-Magsoosi H, Nasear H, Majeed Abbas I Arch Razi Inst. 2023; 77(6):2371-2377.

PMID: 37274870 PMC: 10237565. DOI: 10.22092/ARI.2022.358620.2270.


African based researchers' output on models for the transmission dynamics of infectious diseases and public health interventions: A scoping review.

Adetokunboh O, Mthombothi Z, Dominic E, Djomba-Njankou S, Pulliam J PLoS One. 2021; 16(5):e0250086.

PMID: 33956823 PMC: 8101744. DOI: 10.1371/journal.pone.0250086.


Partnership dynamics in mathematical models and implications for representation of sexually transmitted infections: a review.

Rao D, Wheatley M, Goodreau S, Enns E Ann Epidemiol. 2021; 59:72-80.

PMID: 33930528 PMC: 8259505. DOI: 10.1016/j.annepidem.2021.04.012.


References
1.
Althaus C, Heijne J, Roellin A, Low N . Transmission dynamics of Chlamydia trachomatis affect the impact of screening programmes. Epidemics. 2011; 2(3):123-131. DOI: 10.1016/j.epidem.2010.04.002. View

2.
Brunham R, Pourbohloul B, Mak S, White R, Rekart M . The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis. 2005; 192(10):1836-44. DOI: 10.1086/497341. View

3.
de Vries R, van Bergen J, de Jong-van den Berg L, Postma M . Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data. Value Health. 2006; 9(1):1-11. DOI: 10.1111/j.1524-4733.2006.00075.x. View

4.
Buhaug H, Skjeldestad F, Halvorsen L, Dalen A . Should asymptomatic patients be tested for Chlamydia trachomatis in general practice?. Br J Gen Pract. 1990; 40(333):142-5. PMC: 1371240. View

5.
Gift T, Gaydos C, Kent C, Marrazzo J, Rietmeijer C, Schillinger J . The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women. Sex Transm Dis. 2008; 35(11 Suppl):S66-75. DOI: 10.1097/OLQ.0b013e31818b64ac. View